EX-4.2





 Exhibit 4.2 

LUCIRA HEALTH, INC. 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT 

THIS AMENDED AND RESTATED INVESTOR RIGHTS
AGREEMENT (this “Agreement”), is made as of the 7th day of August, 2020, by and among Lucira Health, Inc., a Delaware corporation (the
“Company”), each of the investors listed on SCHEDULE A hereto, each of which is referred to in this Agreement as an “Investor”, and any Additional Purchaser (as defined in the
Purchase Agreement) that becomes a party to this Agreement in accordance with Section 6.9 hereof. 

RECITALS 

WHEREAS, certain of the Investors (the “Existing Investors”) hold shares of the Company’s Series A
Preferred Stock, Series B Preferred Stock and/or shares of Common Stock issued upon conversion thereof and possess registration rights, information rights, rights of first offer, and other rights pursuant to that certain Amended and Restated
Investor Rights Agreement dated as of March 11, 2019, by and among the Company and such Existing Investors (the “Prior Agreement”); and 

WHEREAS, the Existing Investors are holders of at least a majority of the Registrable Securities of the Company (as defined in the
Prior Agreement) which majority includes the Major Investors (as defined in the Prior Agreement) holding a majority of the Registrable Securities held by all Major Investors (the “Requisite Majority”), and desire to amend and
restate the Prior Agreement in its entirety and to accept the rights created pursuant to this Agreement in lieu of the rights granted to them under the Prior Agreement; and 

WHEREAS, certain of the Investors are parties to that certain Series C Preferred Stock Purchase Agreement of even date herewith by and
among the Company and such Investors (the “Purchase Agreement”), under which certain of the Company’s and such Investors’ obligations are conditioned upon the execution and delivery of this Agreement by such
Investors, Existing Investors holding at least the Requisite Majority, and the Company; 
 NOW,
THEREFORE, the parties hereby agree as follows: 
 1.
DEFINITIONS. For purposes of this Agreement: 
 1.1 “Affiliate” means,
with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or is under common control with such Person, including without limitation any general partner, managing member, officer or director of
such Person or any venture capital fund now or hereafter existing that is controlled by one or more general partners or managing members of, or shares the same management company with, such Person. 

1.2 “Board of Directors” means the Company’s Board of Directors. 

1.3 “Common Stock” means shares of the Company’s common stock, par value $0.001 per share. 

1.4 “Competitor” means a Person engaged, directly or indirectly (including through any partnership,
limited liability company, corporation, joint venture or similar arrangement (whether now existing or formed hereafter)), in nucleic acid testing, but shall not include (a) Eclipse Ventures Fund I, L.P. or its Affiliates (collectively,
“EVFI”), (b) Eclipse Fund III, L.P. or its Affiliates (collectively, “EF III”), (c) Seraph Group LLC or its Affiliates (collectively, “Seraph”), (d) EPQ LLC, LFLU PS or its
Affiliates 












 
(collectively, “EPQ LFLU”), EPQ LLC, LCOVD PS or its Affiliates (collectively, “EPQ LCOVD”), (e) Phoenix Venture Partners III LP or its Affiliates
(collectively, “PVP”), or (f) any financial investment firm or collective investment vehicle that, together with its Affiliates, holds less than ten percent (10%) of the outstanding equity of any Competitor and does not,
nor do any of its Affiliates, have a right to designate any members of the board of directors of any Competitor. 
 1.5
“Damages” means any loss, damage, claim or liability (joint or several) to which a party hereto may become subject under the Securities Act, the Exchange Act, or other federal or state law, insofar as such loss, damage, claim
or liability (or any action in respect thereof) arises out of or is based upon: (i) any untrue statement or alleged untrue statement of a material fact contained in any registration statement of the Company, including any preliminary prospectus
or final prospectus contained therein or any amendments or supplements thereto; (ii) an omission or alleged omission to state therein a material fact required to be stated therein, or necessary to make the statements therein not misleading; or
(iii) any violation or alleged violation by the indemnifying party (or any of its agents or Affiliates) of the Securities Act, the Exchange Act, any state securities law, or any rule or regulation promulgated under the Securities
Act, the Exchange Act, or any state securities law. 
 1.6 “Derivative Securities” means any securities or
rights convertible into, or exercisable or exchangeable for (in each case, directly or indirectly), Common Stock, including options and warrants. 

1.7 “Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations
promulgated thereunder. 
 1.8 “Excluded Registration” means (i) a registration relating to the sale of
securities to employees of the Company or a subsidiary pursuant to a stock option, stock purchase, or similar plan; (ii) a registration relating to an SEC Rule 145 transaction; (iii) a registration on any form that does not include
substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable Securities; or (iv) a registration in which the only Common Stock being registered is Common Stock issuable
upon conversion of debt securities that are also being registered. 
 1.9 “FOIA Party” means a Person that,
in the determination of the Board of Directors, may be subject to, and thereby required to disclose non-public information furnished by or relating to the Company under, the Freedom of Information Act,
5 U.S.C. 552 (“FOIA”), any state public records access law, any state or other jurisdiction’s laws similar in intent or effect to FOIA, or any other similar statutory or regulatory requirement. 

1.10 “Form S-1” means such form under the Securities Act
as in effect on the date hereof or any successor registration form under the Securities Act subsequently adopted by the SEC. 
 1.11
“Form S-3” means such form under the Securities Act as in effect on the date hereof or any registration form under the Securities Act subsequently adopted by the SEC that
permits incorporation of substantial information by reference to other documents filed by the Company with the SEC. 
 1.12
“GAAP” means generally accepted accounting principles in the United States. 
 1.13
“Holder” means any holder of Registrable Securities who is a party to this Agreement. 

  
 2 













 1.14 “Immediate Family Member” means a child, stepchild,
grandchild, parent, stepparent, grandparent, spouse, sibling, mother-in-law,
father-in-law, son-in-law, daughter-in-law, brother-in-law, or
sister-in-law, including, adoptive relationships, of a natural person referred to herein. 

1.15 “Initiating Holders” means, collectively, Holders who properly initiate a registration request under this
Agreement. 
 1.16 “IPO” means the Company’s first underwritten public offering of its Common Stock
under the Securities Act. 
 1.17 “Major Investor” means any Investor that, individually or together with
such Investor’s Affiliates, holds at least (i) 2,000,000 shares of Series A Preferred Stock and/or Series B Preferred Stock (as adjusted for any stock split, stock dividend, combination, or other recapitalization or reclassification effected
after the date hereof); or (ii) 8,000,000 shares of Series C Preferred Stock (as adjusted for any stock split, stock dividend, combination, or other recapitalization or reclassification effected after the date hereof). Notwithstanding the foregoing,
Y Combinator Continuity Fund I, L.P. and YCVC Fund I, L.P. shall each be considered a Major Investor for the purposes of the right of first offer set forth in Section 4 hereof. 

1.18 “New Securities” means, collectively, equity securities of the Company, whether or not currently
authorized, as well as rights, options, or warrants to purchase such equity securities, or securities of any type whatsoever that are, or may become, convertible or exchangeable into or exercisable for such equity securities. 

1.19 “Person” means any individual, corporation, partnership, trust, limited liability company, association or
other entity. 
 1.20 “Preferred Directors” means any director of the Company that the holders
of record of any series of Preferred Stock are entitled to elect pursuant to the Restated Certificate. 
 1.21 “Preferred
Stock” means, collectively, shares of the Company’s Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock. 

1.22 “Registrable Securities” means (i) the Common Stock issuable or issued upon conversion of the
Preferred Stock, (ii) any Common Stock currently held or subsequently acquired by the Investors or any Common Stock issued or issuable (directly or indirectly) upon conversion and/or exercise of any other securities of the
Company, and (iii) any Common Stock issued as (or issuable upon the conversion or exercise of any warrant, right, or other security that is issued as) a dividend or other distribution with respect to, or in exchange for or in replacement of,
the shares referenced in clauses (i) and (ii) above; excluding in all cases, however, any Registrable Securities sold by a Person in a transaction in which the applicable rights under this Agreement are not
assigned pursuant to Subsection 6.1, and excluding for purposes of Section 2 any shares for which registration rights have terminated pursuant to Subsection 2.13 of this Agreement. 

1.23 “Registrable Securities then outstanding” means the number of shares determined by adding the number of
shares of outstanding Common Stock that are Registrable Securities and the number of shares of Common Stock issuable (directly or indirectly) pursuant to then exercisable and/or convertible securities that are Registrable Securities. 

1.24 “Restated Certificate” means the Company’s Fourth Amended and Restated Certificate of Incorporation,
as in effect as of the date hereof. 

  
 3 













 1.25 “Restricted Securities” means the securities of the
Company required to be notated with the legend set forth in Subsection 2.12(b) hereof. 
 1.26 “SEC”
means the Securities and Exchange Commission. 
 1.27 “SEC Rule 144” means Rule 144 promulgated by the SEC
under the Securities Act. 
 1.28 “SEC Rule 145” means Rule 145 promulgated by the SEC under the Securities
Act. 
 1.29 “Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations
promulgated thereunder. 
 1.30 “Selling Expenses” means all underwriting discounts, selling commissions, and
stock transfer taxes applicable to the sale of Registrable Securities, and fees and disbursements of counsel for any Holder, except for the fees and disbursements of the Selling Holder Counsel borne and paid by the Company as provided in
Subsection 2.6. 
 1.31 “Series A Preferred Stock” means shares of the Company’s Series A
Preferred Stock, par value $0.001 per share. 
 1.32 “Series B Preferred Stock” means shares of the
Company’s Series B Preferred Stock, par value $0.001 per share. 
 1.33 “Series C Preferred Stock”
means shares of the Company’s Series C Preferred Stock, par value $0.001 per share. 
 2. REGISTRATION
RIGHTS. The Company covenants and agrees as follows: 
 2.1 Demand Registration. 

(a) Form S-1 Demand. If at any time after the earlier of (i) five (5) years after
the date of this Agreement or (ii) one hundred eighty (180) days after the effective date of the registration statement for the IPO, the Company receives a request from Holders of at least forty percent (40%) of the Registrable Securities
then outstanding that the Company file a Form S-1 registration statement with respect to at least thirty percent (30%) of the Registrable Securities then outstanding (or a lesser percent if the
anticipated aggregate offering price, net of Selling Expenses, would exceed $10 million), then the Company shall (x) within ten (10) days after the date such request is given, give notice thereof (the “Demand
Notice”) to all Holders other than the Initiating Holders; and (y) as soon as practicable, and in any event within sixty (60) days after the date such request is given by the Initiating Holders, file a Form S-1 registration statement under the Securities Act covering all Registrable Securities that the Initiating Holders requested to be registered and any additional Registrable Securities requested to be
included in such registration by any other Holders, as specified by notice given by each such Holder to the Company within twenty (20) days of the date the Demand Notice is given, and in each case, subject to the limitations of Subsections
2.1(c) and 2.3. 
 (b) Form S-3 Demand. If at any time when it is eligible
to use a Form S-3 registration statement, the Company receives a request from Holders of at least twenty percent (20%) of the Registrable Securities then outstanding that the Company file a Form S-3 registration statement with respect to outstanding Registrable Securities of such Holders having an anticipated aggregate offering price, 

  
 4 













 
net of Selling Expenses, of at least $2 million, then the Company shall (i) within ten (10) days after the date such request is given, give a Demand Notice to all Holders other
than the Initiating Holders; and (ii) as soon as practicable, and in any event within thirty (30) days after the date such request is given by the Initiating Holders, file a Form S-3 registration
statement under the Securities Act covering all Registrable Securities requested to be included in such registration by any other Holders, as specified by notice given by each such Holder to the Company within twenty (20) days of the date the
Demand Notice is given, and in each case, subject to the limitations of Subsections 2.1(c) and 2.3. 
 (c)
Notwithstanding the foregoing obligations, if the Company furnishes to Holders requesting a registration pursuant to this Subsection 2.1 a certificate signed by the Company’s chief executive officer stating that in the good faith
judgment of the Board of Directors it would be materially detrimental to the Company and its stockholders for such registration statement to either become effective or remain effective for as long as such registration statement otherwise would be
required to remain effective, because such action would (i) materially interfere with a significant acquisition, corporate reorganization, or other similar transaction involving the Company; (ii) require premature disclosure of material
information that the Company has a bona fide business purpose for preserving as confidential; or (iii) render the Company unable to comply with requirements under the Securities Act or Exchange Act, then the Company shall have the right to
defer taking action with respect to such filing, and any time periods with respect to filing or effectiveness thereof shall be tolled correspondingly, for a period of not more than one hundred twenty (120) days after the request of the
Initiating Holders is given; provided, however, that the Company may not invoke this right more than once in any twelve (12) month period ; and provided further that the Company shall not register any securities for
its own account or that of any other stockholder during such one hundred twenty (120) day period pursuant to a registration relating to the sale of securities to employees of the Company or a subsidiary pursuant to a stock option, stock
purchase, or similar plan; a registration on any form that does not include substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable Securities; or a registration in
which the only Common Stock being registered is Common Stock issuable upon conversion of debt securities that are also being registered. 

(d) The Company shall not be obligated to effect, or to take any action to effect, any registration pursuant to Subsection
2.1(a)(i) during the period that is sixty (60) days before the Company’s good faith estimate of the date of filing of, and ending on a date that is one hundred eighty (180) days after the effective date of, a Company-initiated
registration, provided that the Company is actively employing in good faith commercially reasonable efforts to cause such registration statement to become effective; (ii) after the Company has effected one registration pursuant to
Subsection 2.1(a); or (iii) if the Initiating Holders propose to dispose of shares of Registrable Securities that may be immediately registered on Form S-3 pursuant to a request made pursuant to
Subsection 2.1(b). The Company shall not be obligated to effect, or to take any action to effect, any registration pursuant to Subsection 2.1(b) (i) during the period that is thirty (30) days before the Company’s good
faith estimate of the date of filing of, and ending on a date that is ninety (90) days after the effective date of, a Company-initiated registration, provided that the Company is actively employing in good faith commercially reasonable
efforts to cause such registration statement to become effective; or (ii) if the Company has effected a registration pursuant to Subsection 2.1(b) within the twelve (12) month period immediately preceding the date of such request. A
registration shall not be counted as “effected” for purposes of this Subsection 2.1(d) (i) until such time as the applicable registration statement has been declared effective by the SEC, unless the Initiating Holders withdraw
their request for such registration, elect not to pay the registration expenses therefor, and forfeit their right to one demand registration statement pursuant to Subsection 2.6, in which case such withdrawn registration statement shall be
counted as “effected” for purposes of this Subsection 2.1(d) or (ii) if, as a result of an exercise of the underwriter’s cutback provisions, fewer than fifty percent (50%) of the total number of Registrable Securities that
Holders have requested to be included in such registration statement are actually included. 

  
 5 













 2.2 Company Registration. If the Company proposes to register (including, for
this purpose, a registration effected by the Company for stockholders other than the Holders) any of its Common Stock under the Securities Act in connection with the public offering of such securities solely for cash (other than in an Excluded
Registration), the Company shall, at such time, promptly give each Holder notice of such registration. Upon the request of each Holder given within twenty (20) days after such notice is given by the Company, the Company shall, subject to the
provisions of Subsection 2.3, cause to be registered all of the Registrable Securities that each such Holder has requested to be included in such registration. The Company shall have the right to terminate or withdraw any registration
initiated by it under this Subsection 2.2 before the effective date of such registration, whether or not any Holder has elected to include Registrable Securities in such registration. The expenses (other than Selling Expenses) of such
withdrawn registration shall be borne by the Company in accordance with Subsection 2.6. 
 2.3 Underwriting Requirements. 

(a) If, pursuant to Subsection 2.1, the Initiating Holders intend to distribute the Registrable Securities covered by
their request by means of an underwriting, they shall so advise the Company as a part of their request made pursuant to Subsection 2.1, and the Company shall include such information in the Demand Notice. The underwriter(s) will be selected
by the Company and shall be reasonably acceptable to a majority in interest of the Initiating Holders. In such event, the right of any Holder to include such Holder’s Registrable Securities in such registration shall be conditioned upon such
Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting to the extent provided herein. All Holders proposing to distribute their securities through such underwriting shall
(together with the Company as provided in Subsection 2.4(e)) enter into an underwriting agreement in customary form with the underwriter(s) selected for such underwriting. Notwithstanding any other provision of this Subsection 2.3, if
the managing underwriter(s) advise(s) the Initiating Holders in writing that marketing factors require a limitation on the number of shares to be underwritten, then the Initiating Holders shall so advise all Holders of Registrable Securities that
otherwise would be underwritten pursuant hereto, and the number of Registrable Securities that may be included in the underwriting shall be allocated among such Holders of Registrable Securities, including the Initiating Holders, in proportion (as
nearly as practicable) to the number of Registrable Securities owned by each Holder and submitted for inclusion in such offering or in such other proportion as shall mutually be agreed to by all such selling Holders; provided, however,
that the number of Registrable Securities held by the Holders to be included in such underwriting shall not be reduced unless all other securities are first entirely excluded from the underwriting. To facilitate the allocation of shares in
accordance with the above provisions, the Company or the underwriters may round the number of shares allocated to any Holder to the nearest one hundred (100) shares. 

(b) In connection with any offering involving an underwriting of shares of the Company’s capital stock pursuant to Subsection
2.2, the Company shall not be required to include any of the Holders’ Registrable Securities in such underwriting unless the Holders accept the terms of the underwriting as agreed upon between the Company and its underwriters, and then only
in such quantity as the underwriters in their sole discretion determine will not jeopardize the success of the offering by the Company. If the total number of securities, including Registrable Securities, requested by stockholders to be included in
such offering exceeds the number of securities to be sold (other than by the Company) that the underwriters in their reasonable discretion determine is compatible with the success of the offering, then the Company shall be required to include in the
offering only that number of such securities, including Registrable Securities, which the underwriters and the Company in their sole discretion determine will not jeopardize the success of the offering. If the underwriters determine that less than
all of the Registrable Securities requested to be registered can be included in such offering, then the Registrable Securities that are included in such offering shall be allocated among the selling Holders in proportion (as nearly as practicable
to) the number of Registrable Securities owned by each selling Holder or in such other 

  
 6 













 
proportions as shall mutually be agreed to by all such selling Holders. To facilitate the allocation of shares in accordance with the above provisions, the Company or the underwriters may round
the number of shares allocated to any Holder to the nearest one hundred (100) shares. Notwithstanding the foregoing, in no event shall (i) the number of Registrable Securities included in the offering be reduced unless all other securities
(other than securities to be sold by the Company) are first entirely excluded from the offering, or (ii) the number of Registrable Securities included in the offering be reduced below twenty percent (20%) of the total number of securities
included in such offering, unless such offering is the IPO, in which case the selling Holders may be excluded further if the underwriters make the determination described above and no other stockholder’s securities are included in such
offering. For purposes of the provision in this Subsection 2.3(b) concerning apportionment, for any selling Holder that is a partnership, limited liability company, or corporation, the partners, members, retired partners, retired members,
stockholders, and Affiliates of such Holder, or the estates and Immediate Family Members of any such partners, retired partners, members, and retired members and any trusts for the benefit of any of the foregoing Persons, shall be deemed to be a
single “selling Holder,” and any pro rata reduction with respect to such “selling Holder” shall be based upon the aggregate number of Registrable Securities owned by all Persons included in such “selling Holder,” as
defined in this sentence. 
 2.4 Obligations of the Company. Whenever required under this Section 2
to effect the registration of any Registrable Securities, the Company shall, as expeditiously as reasonably possible: 
 (a) prepare
and file with the SEC a registration statement with respect to such Registrable Securities and use its commercially reasonable efforts to cause such registration statement to become effective and, upon the request of the Holders of a majority of the
Registrable Securities registered thereunder, keep such registration statement effective for a period of up to one hundred twenty (120) days or, if earlier, until the distribution contemplated in the registration statement has been completed;
provided, however, that (i) such one hundred twenty (120) day period shall be extended for a period of time equal to the period the Holder refrains, at the request of an underwriter of Common Stock (or other securities) of
the Company, from selling any securities included in such registration; 
 (b) prepare and file with the SEC such amendments and
supplements to such registration statement, and the prospectus used in connection with such registration statement, as may be necessary to comply with the Securities Act in order to enable the disposition of all securities covered by such
registration statement; 
 (c) furnish to the selling Holders such numbers of copies of a prospectus, including a preliminary
prospectus, as required by the Securities Act, and such other documents as the Holders may reasonably request in order to facilitate their disposition of their Registrable Securities; 

(d) use its commercially reasonable efforts to register and qualify the securities covered by such registration statement under such
other securities or blue-sky laws of such jurisdictions as shall be reasonably requested by the selling Holders; provided that the Company shall not be required to qualify to do business or to file a
general consent to service of process in any such states or jurisdictions, unless the Company is already subject to service in such jurisdiction and except as may be required by the Securities Act; 

(e) immediately notify each Holder of Registrable Securities covered by such registration statement at any time when a prospectus
relating thereto is required to be delivered under the Securities Act of the happening of any event as a result of which the prospectus included in such registration statement, as then in effect, includes an untrue statement of a material fact or
omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing, and at the request of the Holders promptly prepare and furnish to the Holders


  
 7 













 
a reasonable number of copies of a supplement to, or an amendment of, such prospectus as may be necessary so that, as thereafter delivered to the purchasers of such securities, such prospectus
shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances under which they were made; 

(f) in the event of any underwritten public offering, enter into and perform its obligations under an underwriting agreement, in usual
and customary form, with the underwriter(s) of such offering; 
 (g) cause senior representatives of the Company to participate in
any “road show” or “road shows” reasonably requested by any underwriter of an underwritten or “best efforts” offering of any Registrable Securities; 

(h) use its commercially reasonable efforts to furnish, on the date that such Registrable Securities are delivered to the underwriters
for sale, if such securities are being sold through underwriters, (i) an opinion, dated as of such date, of the counsel representing the Company for the purposes of such registration, in form and substance as is customarily given to
underwriters in an underwritten public offering, addressed to the underwriters, if any, and (ii) a letter dated as of such date, from the independent public accountants of the Company, in form and substance as is customarily given by
independent public accountants to underwriters in an underwritten public offering addressed to the underwriters; 
 (i) cooperate
with the sellers and the managing underwriter to facilitate the timely preparation and delivery of certificates (which shall not bear any restrictive legends unless required under applicable law) representing securities sold under any registration
statement, and enable such securities to be in such denominations and registered in such names as the managing underwriter or such sellers may request and keep available and make available to the Company’s transfer agent prior to the
effectiveness of such registration statement a supply of such certificates; 
 (j) use its commercially reasonable efforts to cause
all such Registrable Securities covered by such registration statement to be listed on a national securities exchange or trading system and each securities exchange and trading system (if any) on which similar securities issued by the Company are
then listed; 
 (k) provide a transfer agent and registrar for all Registrable Securities registered pursuant to this Agreement and
provide a CUSIP number for all such Registrable Securities, in each case not later than the effective date of such registration; 

(l) promptly make available for inspection by the selling Holders, any managing underwriter(s) participating in any disposition
pursuant to such registration statement, and any attorney or accountant or other agent retained by any such underwriter or selected by the selling Holders, all financial and other records, pertinent corporate documents, and properties of the
Company, and cause the Company’s officers, directors, employees, and independent accountants to supply all information reasonably requested by any such seller, underwriter, attorney, accountant, or agent, in each case, as necessary or advisable
to verify the accuracy of the information in such registration statement and to conduct appropriate due diligence in connection therewith; 

(m) notify each selling Holder, promptly after the Company receives notice thereof, of the time when such registration statement has
been declared effective or a supplement to any prospectus forming a part of such registration statement has been filed; and 

  
 8 













 (n) after such registration statement becomes effective, notify each selling Holder
of any request by the SEC that the Company amend or supplement such registration statement or prospectus. 
 In addition, the Company shall
ensure that, at all times after any registration statement covering a public offering of securities of the Company under the Securities Act shall have become effective, its insider trading policy shall provide that the Company’s directors may
implement a trading program under Rule 10b5-1 of the Exchange Act. 
 2.5 Furnish
Information. It shall be a condition precedent to the obligations of the Company to take any action pursuant to this Section 2 with respect to the Registrable Securities of any selling Holder that such Holder shall
furnish to the Company such information regarding itself, the Registrable Securities held by it, and the intended method of disposition of such securities as is reasonably required to effect the registration of such Holder’s Registrable
Securities. 
 2.6 Expenses of Registration. All expenses (other than Selling Expenses) incurred in connection with
registrations, filings, or qualifications pursuant to Section 2, including all registration, filing, and qualification fees; printers’ and accounting fees; fees and disbursements of counsel for the Company; and the
reasonable fees and disbursements, not to exceed $35,000, of one counsel for the selling Holders selected by a majority-in-interest of the selling Holders
(“Selling Holder Counsel”), shall be borne and paid by the Company; provided, however, that the Company shall not be required to pay for any expenses of any registration proceeding begun pursuant to
Subsection 2.1 if the registration request is subsequently withdrawn at the request of the Holders of a majority of the Registrable Securities to be registered (in which case all selling Holders shall bear such expenses pro rata based upon
the number of Registrable Securities that were to be included in the withdrawn registration), unless the Holders of a majority of the Registrable Securities agree to forfeit their right to one registration pursuant to Subsections 2.1(a) or
2.1(b), as the case may be. All Selling Expenses relating to Registrable Securities registered pursuant to this Section 2 shall be borne and paid by the Holders pro rata on the basis of the number of Registrable
Securities registered on their behalf. 
 2.7 Delay of Registration. No Holder shall have any right to obtain or seek an
injunction restraining or otherwise delaying any registration pursuant to this Agreement as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 2. 

2.8 Indemnification. If any Registrable Securities are included in a registration statement under this
Section 2: 
 (a) To the extent permitted by law, the Company will indemnify and hold harmless each
selling Holder, and the partners, members, officers, directors, and stockholders of each such Holder; legal counsel and accountants for each such Holder; any underwriter (as defined in the Securities Act) for each such Holder; and each Person, if
any, who controls such Holder or underwriter within the meaning of the Securities Act or the Exchange Act, against any Damages, and the Company will pay to each such Holder, underwriter, controlling Person, or other aforementioned Person any legal
or other expenses reasonably incurred thereby in connection with investigating or defending any claim or proceeding from which Damages may result, as such expenses are incurred; provided, however, that the indemnity agreement contained
in this Subsection 2.8(a) shall not apply to amounts paid in settlement of any such claim or proceeding if such settlement is effected without the consent of the Company, which consent shall not be unreasonably withheld, nor shall the Company
be liable for any Damages to the extent that they arise out of or are based upon actions or omissions made in reliance upon and in conformity with written information furnished by or on behalf of any such Holder, underwriter, controlling Person, or
other aforementioned Person expressly for use in connection with such registration. 

  
 9 













 (b) To the extent permitted by law, each selling Holder, severally and not jointly,
will indemnify and hold harmless the Company, and each of its directors, each of its officers who has signed the registration statement, each Person (if any), who controls the Company within the meaning of the Securities Act, legal counsel and
accountants for the Company, any underwriter (as defined in the Securities Act), any other Holder selling securities in such registration statement, and any controlling Person of any such underwriter or other Holder, against any Damages, in each
case only to the extent that such Damages arise out of or are based upon actions or omissions made in reliance upon and in conformity with written information furnished by or on behalf of such selling Holder expressly for use in connection with such
registration; and each such selling Holder will pay to the Company and each other aforementioned Person any legal or other expenses reasonably incurred thereby in connection with investigating or defending any claim or proceeding from which Damages
may result, as such expenses are incurred; provided, however, that the indemnity agreement contained in this Subsection 2.8(b) shall not apply to amounts paid in settlement of any such claim or proceeding if such settlement is
effected without the consent of the Holder, which consent shall not be unreasonably withheld; and provided further that in no event shall the aggregate amounts payable by any Holder by way of indemnity or contribution under
Subsections 2.8(b) and 2.8(d) exceed the proceeds from the offering received by such Holder (net of any Selling Expenses paid by such Holder), except in the case of fraud or willful misconduct by such Holder. 

(c) Promptly after receipt by an indemnified party under this Subsection 2.8 of notice of the commencement of any action
(including any governmental action) for which a party may be entitled to indemnification hereunder, such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Subsection 2.8, give the
indemnifying party notice of the commencement thereof. The indemnifying party shall have the right to participate in such action and, to the extent the indemnifying party so desires, participate jointly with any other indemnifying party to which
notice has been given, and to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified party (together with all other indemnified parties that may be represented without
conflict by one counsel) shall have the right to retain one separate counsel, with the fees and expenses to be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party would be
inappropriate due to actual or potential differing interests between such indemnified party and any other party represented by such counsel in such action. The failure to give notice to the indemnifying party within a reasonable time of the
commencement of any such action shall relieve such indemnifying party of any liability to the indemnified party under this Subsection 2.8, to the extent that such failure materially prejudices the indemnifying party’s ability to defend
such action. The failure to give notice to the indemnifying party will not relieve it of any liability that it may have to any indemnified party otherwise than under this Subsection 2.8. 

(d) To provide for just and equitable contribution to joint liability under the Securities Act in any case in which either:
(i) any party otherwise entitled to indemnification hereunder makes a claim for indemnification pursuant to this Subsection 2.8 but it is judicially determined (by the entry of a final judgment or decree by a court of competent
jurisdiction and the expiration of time to appeal or the denial of the last right of appeal) that such indemnification may not be enforced in such case, notwithstanding the fact that this Subsection 2.8 provides for indemnification in such
case, or (ii) contribution under the Securities Act may be required on the part of any party hereto for which indemnification is provided under this Subsection 2.8, then, and in each such case, such parties will contribute to the
aggregate losses, claims, damages, liabilities, or expenses to which they may be subject (after contribution from others) in such proportion as is appropriate to reflect the relative fault of each of the indemnifying party and the indemnified party
in connection with the statements, omissions, or other actions that resulted in such loss, claim, damage, liability, or expense, as well as to reflect any other relevant equitable considerations. The relative fault of the indemnifying party and of
the indemnified party shall be determined by reference to, among other things, whether the untrue or allegedly untrue statement of a material fact, or the omission or alleged omission of a material fact, relates to information supplied by the


  
 10 













 
indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information, and opportunity to correct or prevent such statement or omission;
provided, however, that, in any such case (x) no Holder will be required to contribute any amount in excess of the public offering price of all such Registrable Securities offered and sold by such Holder pursuant to such
registration statement, and (y) no Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) will be entitled to contribution from any Person who was not guilty of such fraudulent
misrepresentation; and provided further that in no event shall a Holder’s liability pursuant to this Subsection 2.8(d), when combined with the amounts paid or payable by such Holder pursuant to Subsection 2.8(b),
exceed the proceeds from the offering received by such Holder (net of any Selling Expenses paid by such Holder), except in the case of willful misconduct or fraud by such Holder. 

(e) Notwithstanding the foregoing, to the extent that the provisions on indemnification and contribution contained in the underwriting
agreement entered into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions in the underwriting agreement shall control. 

(f) Unless otherwise superseded by an underwriting agreement entered into in connection with the underwritten public offering, the
obligations of the Company and Holders under this Subsection 2.8 shall survive the completion of any offering of Registrable Securities in a registration under this Section 2, and otherwise shall survive the
termination of this Agreement. 
 2.9 Reports Under Exchange Act. With a view to making available to the Holders the benefits
of SEC Rule 144 and any other rule or regulation of the SEC that may at any time permit a Holder to sell securities of the Company to the public without registration or pursuant to a registration on Form S-3,
the Company shall: 
 (a) make and keep available adequate current public information, as those terms are understood and defined in
SEC Rule 144, at all times after the effective date of the registration statement filed by the Company for the IPO; 
 (b) use
commercially reasonable efforts to file with the SEC in a timely manner all reports and other documents required of the Company under the Securities Act and the Exchange Act (at any time after the Company has become subject to such reporting
requirements); and 
 (c) furnish to any Holder, so long as the Holder owns any Registrable Securities, forthwith upon request
(i) to the extent accurate, a written statement by the Company that it has complied with the reporting requirements of SEC Rule 144 (at any time after ninety (90) days after the effective date of the registration statement filed by the
Company for the IPO), the Securities Act, and the Exchange Act (at any time after the Company has become subject to such reporting requirements), or that it qualifies as a registrant whose securities may be resold pursuant to Form S-3 (at any time after the Company so qualifies); (ii) a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company; and (iii) such other
information as may be reasonably requested in availing any Holder of any rule or regulation of the SEC that permits the selling of any such securities without registration (at any time after the Company has become subject to the reporting
requirements under the Exchange Act) or pursuant to Form S-3 (at any time after the Company so qualifies to use such form). 

2.10 Limitations on Subsequent Registration Rights. From and after the date of this Agreement, the Company shall not, without
the prior written consent of the Holders of a majority of the Registrable Securities then outstanding, enter into any agreement with any holder or prospective holder of any securities of the Company that (i) would provide to such holder the
right to include securities in any 

  
 11 













 
registration on other than either a pro rata basis with respect to the Registrable Securities or on a subordinate basis after all Holders have had the opportunity to include in the registration
and offering all shares of Registrable Securities that they wish to so include or (ii) allow such holder or prospective holder to initiate a demand for registration of any securities held by such holder or prospective holder; provided
that this limitation shall not apply to any additional Investor who becomes a party to this Agreement in accordance with Subsection 6.9. 

2.11 “Market Stand-off” Agreement. Each Holder
hereby agrees that it will not, without the prior written consent of the managing underwriter, during the period commencing on the date of the final prospectus relating to the registration by the Company of shares of its Common Stock or any other
equity securities under the Securities Act on a registration statement on Form S-1, and ending on the date specified by the Company and the managing underwriter (such period not to exceed one hundred
eighty (180) days), (i) lend; offer; pledge; sell; contract to sell; sell any option or contract to purchase; purchase any option or contract to sell; grant any option, right, or warrant to purchase; or otherwise transfer or dispose of,
directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable or exchangeable (directly or indirectly) for Common Stock (whether such shares or any such securities are then owned by the Holder or are thereafter
acquired) or (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of such securities, whether any such transaction described in clause (i) or (ii) above
is to be settled by delivery of Common Stock or other securities, in cash, or otherwise. The foregoing provisions of this Subsection 2.11 shall apply only to the IPO and shall not apply to the sale of any shares to an underwriter
pursuant to an underwriting agreement, or the transfer of any shares to any trust for the direct or indirect benefit of the Holder or the immediate family of the Holder, provided that the trustee of the trust agrees to be bound in writing by
the restrictions set forth herein, and provided further that any such transfer shall not involve a disposition for value, and shall be applicable to the Holders only if all officers and directors are subject to the same restrictions
and the Company uses commercially reasonable efforts to obtain a similar agreement from all stockholders individually owning more than one percent (1%) of the Company’s outstanding Common Stock (after giving effect to conversion into Common
Stock of all outstanding Preferred Stock). The underwriters in connection with such registration are intended third-party beneficiaries of this Subsection 2.11 and shall have the right, power and
authority to enforce the provisions hereof as though they were a party hereto. Each Holder further agrees to execute such agreements as may be reasonably requested by the underwriters in connection with such registration that are consistent with
this Subsection 2.11 or that are necessary to give further effect thereto. Any discretionary waiver or termination of the restrictions of any or all of such agreements by the Company or the underwriters shall apply pro rata to all Holders
subject to such agreements, based on the number of shares subject to such agreements. 
 2.12 Restrictions on Transfer. 

(a) The Preferred Stock and the Registrable Securities shall not be sold, pledged, or otherwise transferred, and the Company shall not
recognize and shall issue stop-transfer instructions to its transfer agent with respect to any such sale, pledge, or transfer, except upon the conditions specified in this Agreement, which conditions are intended to ensure compliance with the
provisions of the Securities Act. A transferring Holder will cause any proposed purchaser, pledgee, or transferee of the Preferred Stock and the Registrable Securities held by such Holder to agree to take and hold such securities subject to the
provisions and upon the conditions specified in this Agreement. 
 (b) Each certificate, instrument, or book entry representing
(i) the Preferred Stock, (ii) the Registrable Securities, and (iii) any other securities issued in respect of the securities referenced in clauses (i) and (ii), upon any stock split, stock dividend, recapitalization, merger,
consolidation, or similar event, shall (unless otherwise permitted by the provisions of Subsection 2.12(c)) be notated with a legend substantially in the following form: 

  
 12 













 THE SECURITIES REPRESENTED HEREBY HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933. SUCH SHARES MAY NOT BE SOLD, PLEDGED, OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR A VALID EXEMPTION FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF SAID ACT. 

THE SECURITIES REPRESENTED HEREBY MAY BE TRANSFERRED ONLY IN ACCORDANCE WITH THE TERMS OF AN AGREEMENT BETWEEN THE COMPANY AND THE STOCKHOLDER,
A COPY OF WHICH IS ON FILE WITH THE SECRETARY OF THE COMPANY. 
 The Holders consent to the Company making a notation in its records and
giving instructions to any transfer agent of the Restricted Securities in order to implement the restrictions on transfer set forth in this Subsection 2.12. 

(c) The holder of such Restricted Securities, by acceptance of ownership thereof, agrees to comply in all respects with the provisions
of this Section 2. Before any proposed sale, pledge, or transfer of any Restricted Securities, unless there is in effect a registration statement under the Securities Act covering the proposed transaction, the Holder
thereof shall give notice to the Company of such Holder’s intention to effect such sale, pledge, or transfer. Each such notice shall describe the manner and circumstances of the proposed sale, pledge, or transfer in sufficient detail and, if
reasonably requested by the Company, shall be accompanied at such Holder’s expense by either (i) a written opinion of legal counsel who shall, and whose legal opinion shall, be reasonably satisfactory to the Company, addressed to the
Company, to the effect that the proposed transaction may be effected without registration under the Securities Act; (ii) a “no action” letter from the SEC to the effect that the proposed sale, pledge, or transfer of such Restricted
Securities without registration will not result in a recommendation by the staff of the SEC that action be taken with respect thereto; or (iii) any other evidence reasonably satisfactory to counsel to the Company to the effect that the proposed
sale, pledge, or transfer of the Restricted Securities may be effected without registration under the Securities Act, whereupon the Holder of such Restricted Securities shall be entitled to sell, pledge, or transfer such Restricted Securities in
accordance with the terms of the notice given by the Holder to the Company. The Company will not require such a legal opinion or “no action” letter (x) in any transaction in compliance with SEC Rule 144; or (y) in any transaction
in which such Holder distributes Restricted Securities to an Affiliate of such Holder for no consideration; provided that each transferee agrees in writing to be subject to the terms of this Subsection 2.12. Each certificate,
instrument, or book entry representing the Restricted Securities transferred as above provided shall be notated with, except if such transfer is made pursuant to SEC Rule 144, the appropriate restrictive legend set forth in Subsection
2.12(b), except that such certificate instrument, or book entry shall not be notated with such restrictive legend if, in the opinion of counsel for such Holder and the Company, such legend is not required in order to establish compliance with
any provisions of the Securities Act. 
 2.13 Termination of Registration Rights. The right of any Holder to request
registration or inclusion of Registrable Securities in any registration pursuant to Subsections 2.1 or 2.2 shall terminate upon the earliest to occur of: 

(a) upon a Deemed Liquidation Event, as such term is defined and applied in the Restated Certificate; 

(b) such time after consummation of the IPO as Rule 144 or another similar exemption under the Securities Act is available for the
sale of all of such Holder’s shares without limitation during a three-month period without registration; and 

  
 13 













 (c) the third anniversary of the Qualified IPO (as defined in the Restated
Certificate). 
 3. INFORMATION AND OBSERVER RIGHTS. 

3.1 Delivery of Financial Statements. The Company shall deliver to each Major Investor, provided that the Board of
Directors has not reasonably determined that such Major Investor is a Competitor of the Company: 
 (a) as soon as practicable, but
in any event within one hundred twenty (120) days after the end of each fiscal year of the Company (i) an unaudited balance sheet as of the end of such year, (ii) unaudited statements of income and of cash flows for such year, and
(iii) an unaudited statement of stockholders’ equity as of the end of such year; 
 (b) as soon as practicable, but in any
event within forty-five (45) days after the end of each of the first three (3) quarters of each fiscal year of the Company, unaudited statements of income and cash flows for such fiscal quarter, and
an unaudited balance sheet and a statement of stockholders’ equity as of the end of such fiscal quarter, all prepared in accordance with GAAP (except that such financial statements may (i) be subject to normal year-end audit adjustments; and (ii) not contain all notes thereto that may be required in accordance with GAAP); 

(c) as soon as practicable, but in any event within thirty (30) days of the end of each month, an unaudited income statement and
statement of cash flows for such month, and an unaudited balance sheet and statement of stockholders’ equity as of the end of such month, all prepared in accordance with GAAP (except that such financial statements may (i) be subject to
normal year-end audit adjustments and (ii) not contain all notes thereto that may be required in accordance with GAAP); and 

(d) as soon as practicable, but in any event within thirty (30) days of the end of each fiscal year, a business plan and a budget
for the next fiscal year, prepared on a monthly basis, including balance sheets, income statements, and statements of cash flow for such months and, promptly after prepared, any other budgets or revised budgets prepared by the Company; and 

(e) such other information relating to the financial condition, business, prospects, or corporate affairs of the Company as any Major
Investor may from time to time reasonably request; provided, however, that the Company shall not be obligated under this Subsection 3.1 to provide information (i) that the Company reasonably determines in good faith to be a
trade secret or confidential information (unless covered by an enforceable confidentiality agreement, in a form acceptable to the Company); or (ii) the disclosure of which would adversely affect the attorney-client privilege between the Company
and its counsel. 
 If, for any period, the Company has any subsidiary whose accounts are consolidated with those of the Company, then in
respect of such period the financial statements delivered pursuant to the foregoing sections shall be the consolidated and consolidating financial statements of the Company and all such consolidated subsidiaries. 

Notwithstanding anything else in this Subsection 3.1 to the contrary, the Company may cease providing the information set forth in this
Subsection 3.1 during the period starting with the date sixty (60) days before the Company’s good-faith estimate of the date of filing of a registration statement if it reasonably concludes it must do so to comply with the SEC rules
applicable to such registration statement and related offering; provided that the Company’s covenants under this Subsection 3.1 shall be reinstated at such time as the Company is no longer actively employing its commercially
reasonable efforts to cause such registration statement to become effective. 

  
 14 













 3.2 Inspection. The Company shall permit each Major Investor (provided
that the Board of Directors has not reasonably determined that such Major Investor is a competitor of the Company), at such Major Investor’s expense, to visit and inspect the Company’s properties; examine its books of account and records;
and discuss the Company’s affairs, finances, and accounts with its officers, during normal business hours of the Company as may be reasonably requested by the Major Investor; provided, however, that the Company shall not be
obligated pursuant to this Subsection 3.2 to provide access to any information that it reasonably and in good faith considers to be a trade secret or confidential information (unless covered by an enforceable confidentiality agreement, in
form acceptable to the Company) or the disclosure of which would adversely affect the attorney-client privilege between the Company and its counsel. 

3.3 Termination of Information. The covenants set forth in Subsection 3.1 and Subsection 3.2 shall terminate and
be of no further force or effect (i) immediately before the consummation of the Qualified IPO, or (ii) when the Company first becomes subject to the periodic reporting requirements of Section 12(g) or 15(d) of the Exchange Act,
or (iii) upon a Deemed Liquidation Event, as such term is defined and applied in the Restated Certificate, whichever event occurs first. 

3.4 Confidentiality. Each Investor agrees that such Investor will keep confidential and will not disclose, divulge, or use for
any purpose (other than to monitor its investment in the Company) any confidential information obtained from the Company pursuant to the terms of this Agreement (including notice of the Company’s intention to file a registration statement),
unless such confidential information (a) is known or becomes known to the public in general (other than as a result of a breach of this Subsection 3.4 by such Investor), (b) is or has been independently developed or conceived by the
Investor without use of the Company’s confidential information, or (c) is or has been made known or disclosed to the Investor by a third party without a breach of any obligation of confidentiality such third party may have to the Company;
provided, however, that an Investor may disclose confidential information (i) to its attorneys, accountants, consultants, and other professionals to the extent necessary to obtain their services in connection with monitoring its
investment in the Company; (ii) to any prospective purchaser of any Registrable Securities from such Investor, if such prospective purchaser agrees to be bound by the provisions of this Subsection 3.4; (iii) to any existing
Affiliate, partner, member, stockholder, or wholly owned subsidiary of such Investor in the ordinary course of business, provided that such Investor informs such Person that such information is confidential and directs such Person to maintain
the confidentiality of such information; or (iv) as may otherwise be required by law, provided that the Investor promptly notifies the Company of such disclosure and takes reasonable steps to minimize the extent of any such required
disclosure. 
 4. RIGHTS TO FUTURE STOCK ISSUANCES. 

4.1 Right of First Offer. Subject to the terms and conditions of this Subsection 4.1 and applicable securities laws, if
the Company proposes to offer or sell any New Securities, the Company shall first offer such New Securities to each Major Investor. A Major Investor shall be entitled to apportion the right of first offer hereby granted to it in such proportions as
it deems appropriate, among (i) itself and (ii) its Affiliates, as approved by the Company. 
 (a) The Company shall give
notice (the “Offer Notice”) to each Major Investor, stating (i) its bona fide intention to offer such New Securities, (ii) the number of such New Securities to be offered, and (iii) the price and terms, if any,
upon which it proposes to offer such New Securities. 

  
 15 













 (b) By notification to the Company within twenty (20) days after the Offer
Notice is given, each Major Investor may elect to purchase or otherwise acquire, at the price and on the terms specified in the Offer Notice, up to that portion of such New Securities which equals the proportion that the Common Stock then held by
such Major Investor (including all shares of Common Stock then issuable (directly or indirectly) upon conversion and/or exercise, as applicable, of the Preferred Stock and any other Derivative Securities then held by such Major Investor) bears to
the total Common Stock of the Company then outstanding (assuming full conversion and/or exercise, as applicable, of all Preferred Stock and other Derivative Securities). At the expiration of such twenty (20) day period, the Company shall
promptly notify each Major Investor that elects to purchase or acquire all the shares available to it (each, a “Fully Exercising Investor”) of any other Major Investor’s failure to do likewise. During the ten
(10) day period commencing after the Company has given such notice, each Fully Exercising Investor may, by giving notice to the Company, elect to purchase or acquire, in addition to the number of shares specified above, up to that portion of
the New Securities for which Major Investors were entitled to subscribe but that were not subscribed for by the Major Investors which is equal to the proportion that the Common Stock issued and held, or issuable (directly or indirectly) upon
conversion and/or exercise, as applicable, of Preferred Stock and any other Derivative Securities then held, by such Fully Exercising Investor bears to the Common Stock issued and held, or issuable (directly or indirectly) upon conversion and/or
exercise, as applicable, of the Preferred Stock and any other Derivative Securities then held, by all Fully Exercising Investors who wish to purchase such unsubscribed shares. The closing of any sale pursuant to this Subsection 4.1(b)
shall occur within the later of ninety (90) days of the date that the Offer Notice is given and the date of initial sale of New Securities pursuant to Subsection 4.1(c). 

(c) If all New Securities referred to in the Offer Notice are not elected to be purchased or acquired as provided in Subsection
4.1(b), the Company may, during the sixty (60) day period following the expiration of the periods provided in Subsection 4.1(b), offer and sell the remaining unsubscribed portion of such New Securities to any Person or Persons at a
price not less than, and upon terms no more favorable to the offeree than, those specified in the Offer Notice. If the Company does not enter into an agreement for the sale of the New Securities within such period, or if such agreement is not
consummated within thirty (30) days of the execution thereof, the right provided hereunder shall be deemed to be revived and such New Securities shall not be offered unless first reoffered to the Major Investors in accordance with this
Subsection 4.1. 
 (d) The right of first offer in this Subsection 4.1 shall not be applicable to (i) Exempted
Securities (as defined in the Restated Certificate) and (ii) the issuance of shares of Preferred Stock to Additional Purchasers pursuant to Subsection 1.3 of the Purchase Agreement. 

4.2 Termination. The covenants set forth in Subsection 4.1 shall terminate and be of no further force or effect
(i) immediately before the consummation of the Qualified IPO, (ii) when the Company first becomes subject to the periodic reporting requirements of Section 12(g) or 15(d) of the Exchange Act, or (iii) upon a Deemed Liquidation
Event, whichever event occurs first and, as to each Major Investor, in accordance with Subsection 4.1(e). 
 5.
ADDITIONAL COVENANTS. 
 5.1 Insurance. The Company shall use its commercially reasonable
efforts to maintain Directors and Officers liability insurance in an amount and on terms and conditions satisfactory to the Board of Directors, and will use commercially reasonable efforts to cause such insurance policies to be maintained until such
time as the Board of Directors determines that such insurance should be discontinued. 

  
 16 













 5.2 Employee Agreements. The Company will cause (i) each person now or
hereafter employed by it or by any subsidiary (or engaged by the Company or any subsidiary as a consultant/independent contractor) with access to confidential information and/or trade secrets to enter into a nondisclosure and proprietary rights
assignment agreement in the form approved by the Board of Directors. In addition, the Company shall not amend, modify, terminate, waive, or otherwise alter, in whole or in part, any of the above-referenced agreements or any restricted stock
agreement between the Company and any employee, without the approval of the Board of Directors, including a majority of the Preferred Directors. 

5.3 Employee Stock. Unless otherwise approved by the Board of Directors, all future employees and consultants of the Company who
purchase, receive options to purchase, or receive awards of shares of the Company’s capital stock after the date hereof shall be required to execute restricted stock or option agreements, as applicable, providing for (i) vesting of shares
over a four (4) year period, with the first twenty-five percent (25%) of such shares vesting following twelve (12) months of continued employment or service, and the remaining shares vesting in equal monthly installments over the following
thirty-six (36) months, and (ii) a market stand-off provision substantially similar to that in Subsection 2.11. In addition, unless otherwise approved
by the Board of Directors, the Company shall retain a “right of first refusal” on employee transfers until the Company’s IPO and shall have the right to repurchase unvested shares at cost upon termination of employment of a
holder of restricted stock. 
 5.4 Board Matters. The Company shall reimburse the directors for all reasonable out-of-pocket travel expenses incurred in connection with attending meetings of the Board of Directors. If the current Board of Directors has not yet approved the budget for
the current fiscal year as of the Closing, the Company’s management shall present the budget for the current fiscal year to the Board of Directors for approval by the Board of Directors, in the Board of Directors’ first meeting after the
Closing. 
 5.5 Successor Indemnification. If the Company or any of its successors or assignees consolidates with or
merges into any other Person and is not the continuing or surviving corporation or entity of such consolidation or merger, then to the extent necessary, proper provision shall be made so that the successors and assignees of the Company assume the
obligations of the Company with respect to indemnification of members of the Board of Directors as in effect immediately before such transaction, whether such obligations are contained in the Company’s Bylaws, the Restated Certificate, or
elsewhere, as the case may be. This Section 5.5 shall survive any termination of this Agreement. 
 5.6
Indemnification Matters. The Company hereby acknowledges that one (1) or more of the directors nominated to serve on the Board of Directors by the Investors (each a “Fund Director”) may have certain rights
to indemnification, advancement of expenses and/or insurance provided by one or more of the Investors and certain of their affiliates (collectively, the “Fund Indemnitors”). The Company hereby agrees (a) that it is the
indemnitor of first resort (i.e., its obligations to any such Fund Director are primary and any obligation of the Fund Indemnitors to advance expenses or to provide indemnification for the same expenses or liabilities incurred by such Fund
Director are secondary), (b) that it shall be required to advance the full amount of expenses incurred by such Fund Director and shall be liable for the full amount of all expenses, judgments, penalties, fines and amounts paid in settlement by or on
behalf of any such Fund Director to the extent legally permitted and as required by the Restated Certificate or Bylaws of the Company (or any agreement between the Company and such Fund Director), without regard to any rights such Fund Director may
have against the Fund Indemnitors, and, (c) that it irrevocably waives, relinquishes and releases the Fund Indemnitors from any and all claims against the Fund Indemnitors for contribution, subrogation or any other recovery of any kind in
respect thereof. The Company further agrees that no advancement or payment by the Fund Indemnitors on behalf of any such Fund Director with respect to any claim for which such Fund Director has sought indemnification from the Company shall
affect the foregoing and the Fund Indemnitors shall have a right of contribution and/or be subrogated to the extent of such advancement or payment to all of the rights of recovery of such Fund Director against the Company. 

  
 17 













 5.7 Right to Conduct Activities. The Company hereby agrees and acknowledges
that each of EVFI, EF III, Seraph, EPQ LFLU, EPQ LCOVD and PVP together with their respective Affiliates (collectively, the “Venture Investors”), is a professional investment fund, and as such invests in numerous portfolio
companies, some of which may be deemed competitive with the Company’s business (as currently conducted or as currently propose to be conducted). The Company hereby agrees that, to the extent permitted under applicable law, no Venture Investor
shall be liable to the Company for any claim arising out of, or based upon, (i) the investment by a Venture Investor in any entity competitive with the Company, or (ii) actions taken by any partner, officer or other representative of a
Venture Investor to assist any such competitive company, whether or not such action was taken as a member of the board of directors of such competitive company or otherwise, and whether or not such action has a detrimental effect on the Company;
provided, however, that the foregoing shall not relieve (x) any Venture Investor from liability associated with the unauthorized disclosure of the Company’s confidential information obtained pursuant to this Agreement, or (y) any
director or officer of the Company from any liability associated with his or her fiduciary duties to the Company. 
 5.8
Termination of Covenants. The covenants set forth in this Section 5 (other than Section 5.5) shall terminate and be of no further force or effect (i) immediately before the consummation of the Qualified IPO, (ii) when the
Company first becomes subject to the periodic reporting requirements of Section 12(g) or 15(d) of the Exchange Act, or (iii) upon a Deemed Liquidation Event, whichever event occurs first. 

6. MISCELLANEOUS. 

6.1 Successors and Assigns. The rights under this Agreement may be assigned (but only with all related obligations) by a
Holder to a transferee of Registrable Securities that (i) is an Affiliate of a Holder; (ii) is a Holder’s Immediate Family Member or trust for the benefit of an individual Holder or one or more of such Holder’s Immediate Family
Members; or (iii) after such transfer, holds at least fifty percent (50%) of the shares of Registrable Securities originally held by the assignor prior to the transfer of shares (subject to appropriate adjustment for stock splits, stock
dividends, combinations, and other recapitalizations); provided, however, that (x) the Company is, within a reasonable time after such transfer, furnished with written notice of the name and address of such transferee and the
Registrable Securities with respect to which such rights are being transferred; and (y) such transferee agrees in a written instrument delivered to the Company to be bound by and subject to the terms and conditions of this Agreement, including
the provisions of Subsection 2.11. For the purposes of determining the number of shares of Registrable Securities held by a transferee, the holdings of a transferee (1) that is an Affiliate or stockholder of a Holder; (2) who is a
Holder’s Immediate Family Member; or (3) that is a trust for the benefit of an individual Holder or such Holder’s Immediate Family Member shall be aggregated together and with those of the transferring Holder; provided
further that all transferees who would not qualify individually for assignment of rights shall have a single attorney-in-fact for the purpose of exercising any
rights, receiving notices, or taking any action under this Agreement. The terms and conditions of this Agreement inure to the benefit of and are binding upon the respective successors and permitted assignees of the parties. Nothing in this
Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and permitted assignees any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as
expressly provided herein. 
 6.2 Governing Law. This Agreement shall be governed by the internal law of the State of
Delaware, without regard to conflict of laws principles. 

  
 18 













 6.3 Counterparts.. This Agreement may be executed in two (2) or more
counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signature complying with
the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act or other applicable law) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all
purposes. 
 6.4 Titles and Subtitles. The titles and subtitles used in this Agreement are for convenience only and are not to
be considered in construing or interpreting this Agreement. 
 6.5 Notices. All notices and other communications given or made
pursuant to this Agreement shall be in writing and shall be deemed effectively given upon the earlier of actual receipt or (i) personal delivery to the party to be notified; (ii) when sent, if sent by electronic mail or facsimile during
the recipient’s normal business hours, and if not sent during normal business hours, then on the recipient’s next business day; (iii) five (5) days after having been sent by registered or certified mail, return receipt requested,
postage prepaid; or (iv) one (1) business day after the business day of deposit with a nationally recognized overnight courier, freight prepaid, specifying next-day delivery, with written verification of
receipt. All communications shall be sent to the respective parties at their addresses as set forth on SCHEDULE A hereto, or to the principal office of the Company and to the attention
of the Chief Executive Officer, in the case of the Company, at the address set forth on the Company signature page hereto; and a copy (which shall not constitute notice) shall also be sent to Cooley LLP, 3175 Hanover Street, Palo Alto, CA 94304,
Attention: Josh Seidenfeld. 
 6.6 Amendments and Waivers. Except as set forth herein, any term of this Agreement may be
amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance, and either retroactively or prospectively) only with the written consent of the Company and the holders of a majority of the
Registrable Securities then outstanding; provided that the Company may in its sole discretion waive compliance with Subsection 2.12(c) (and the Company’s failure to object promptly in writing after notification of a
proposed assignment allegedly in violation of Subsection 2.12(c) shall be deemed to be a waiver); and provided further that any provision hereof may be waived by any waiving party on such party’s own behalf, without
the consent of any other party. Notwithstanding the foregoing, (i) this Agreement may not be amended or terminated and the observance of any term hereof may not be waived with respect to any Investor without the written consent of such
Investor, unless such amendment, termination, or waiver applies to all Investors in the same fashion, (ii) Sections 1.17, 3.1, 3.2, 4, and this clause (ii) may not be amended or terminated and the observance of
any term hereof may not be waived without the prior written consent of the Major Investors holding a majority of the Registrable Securities then outstanding held by all Major Investors (it being agreed that a waiver of the provisions of
Section 4 with respect to a particular transaction shall be deemed to apply to all Major Investors in the same fashion if such waiver does so by its terms, notwithstanding the fact that certain Major Investors may
nonetheless, by agreement with the Company, purchase securities in such transaction), (iii) SCHEDULE A hereto may be amended by the Company from time to time in accordance with the Purchase Agreement to add information
regarding Additional Purchasers (as defined in the Purchase Agreement) without the consent of the other parties hereto, (iv) any provision hereof may be waived by the waiving party on such party’s own behalf, (v) the last sentence of
Subsection 1.17 and this clause (v) may not be amended or waived without the written consent of Y Combinator Continuity Fund I, L.P. and YCVC Fund I, L.P., (vi) Sections 1.4 and 5.7, as applied to EVFI, EF III, Seraph, EPQ
LFLU and EPQ LCOVD, as applicable, may not be amended or terminated and the observance of any term hereof may not be waived without the prior written consent of EVFI, EF III, Seraph, EPQ LFLU and EPQ LCOVD, as applicable. The Company shall give
prompt notice of any amendment or termination hereof or waiver hereunder to any party hereto that did not consent in writing to such amendment, termination, or waiver. Any amendment, termination, or waiver effected in accordance with this
Subsection 6.6 shall be binding on all parties hereto, 

  
 19 













 
regardless of whether any such party has consented thereto. No waivers of or exceptions to any term, condition, or provision of this Agreement, in any one or more instances, shall be deemed to be
or construed as a further or continuing waiver of any such term, condition, or provision. 
 6.7 Severability. In case any one
or more of the provisions contained in this Agreement is for any reason held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality, or unenforceability shall not affect any other provision of this Agreement, and such
invalid, illegal, or unenforceable provision shall be reformed and construed so that it will be valid, legal, and enforceable to the maximum extent permitted by law. 

6.8 Aggregation of Stock. All shares of Registrable Securities held or acquired by Affiliates shall be aggregated together for
the purpose of determining the availability of any rights under this Agreement and such Affiliated persons may apportion such rights as among themselves in any manner they deem appropriate. 

6.9 Additional Investors. Notwithstanding anything to the contrary contained herein, if the Company issues additional shares of
the Company’s Preferred Stock after the date hereof, any purchaser of such shares of Preferred Stock may become a party to this Agreement by executing and delivering an additional counterpart signature page to this Agreement, and thereafter
shall be deemed an “Investor” for all purposes hereunder. No action or consent by the Investors shall be required for such joinder to this Agreement by such additional Investor, so long as such additional Investor has agreed in writing to
be bound by all of the obligations as an “Investor” hereunder. 
 6.10 Specific Performance. In addition to any and
all other remedies that may be available at law in the event of any breach of this Agreement, each Investor shall be entitled to specific performance of the agreements and obligations of the Company hereunder and to such other injunction or other
equitable relief as may be granted by a court of competent jurisdiction. 
 6.11 Further Assurances. At any time or from time
to time after the date hereof, the parties agree to cooperate with each other, and at the request of any other party, to execute and deliver any further instruments or documents and to take all such further action as the other party may reasonably
request in order to evidence or effectuate the consummation of the transactions contemplated hereby and to otherwise carry out the intent of the parties hereunder. 

6.12 Entire Agreement. Upon the effectiveness of this Agreement, the Prior Agreement shall be deemed amended and restated and
superseded and replaced in its entirety by this Agreement and shall be of no further force or effect. This Agreement (including any Schedules hereto) constitutes the full and entire understanding and agreement among the parties with respect to the
subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties is expressly canceled. 

6.13 Dispute Resolution. The parties (a) hereby irrevocably and unconditionally submit to the jurisdiction of the state
courts of California and to the jurisdiction of the United States District Court for the District of Northern California for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (b) agree not to
commence any suit, action or other proceeding arising out of or based upon this Agreement except in the state courts of California or the United States District Court for the District of Northern District, and (c) hereby waive, and agree not to
assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or
execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court. 

  
 20 













 6.14 Attorneys’ Fees. If any action at law or in equity
(including, arbitration) is necessary to enforce or interpret the terms of any of this Agreement, the prevailing party shall be entitled to reasonable attorneys’ fees, costs and necessary disbursements in addition to any other relief to which
such party may be entitled. 
 6.15 Delays or Omissions. No delay or omission to exercise any right, power, or remedy accruing
to any party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power, or remedy of such nonbreaching or nondefaulting party, nor shall it be construed to be a waiver of or
acquiescence to any such breach or default, or to any similar breach or default thereafter occurring, nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. All
remedies, whether under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative. 
 6.16
Acknowledgment. The Company acknowledges that the Investors are in the business of venture capital investing and therefore review the business plans and related proprietary information of many enterprises, including enterprises which may have
products or services which compete directly or indirectly with those of the Company. Nothing in this Agreement shall preclude or in any way restrict the Investors from investing or participating in any particular enterprise whether or not such
enterprise has products or services which compete with those of the Company. 
 [SIGNATURE PAGES
FOLLOW] 

  
 21 













 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	COMPANY:
	
	LUCIRA HEALTH, INC.
		
	By:	 	 /s/ Erik T. Engelson 

	Name:	 	 Erik T. Engelson

	Title:	 	 Chief Executive Officer

		
	Address:	 	 1412 62nd Street

		 	 Emeryville, CA 94608




  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	AISOMI LLC
		
	By:	 	 /s/ Tamara L. Minick-Sokalo

	Name:	 	 Tamara L. Minick-Sokalo

	Title:	 	 Director




  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	BERENSTEIN FAMILY GST EXEMPT 2009 TRUST
		
	By:	 	 /s/ Frank A. Sisti

	Name:	 	 Frank A. Sisti

	Title:	 	 Trustee




  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	BLUE DEVIL TRUST
		
	By:	 	 /s/ David Lamond

	Name:	 	 David Lamond 

	Title:	 	 Trustee




  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	CAROL OLSON LIVING TRUST DATED 6/9/2014
		
	By:	 	 /s/ Carol Olson

	Name:	 	 Carol Olson

	Title:	 	 Trustee




  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	CHRISTINE HANNI
	
	/s/ Christine Hanni
	(Signature)



  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	DAN GEORGE
	
	/s/ Dan George
	(Signature)



  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	DANIEL HEILBRUNN
	
	/s/ Daniel Heilbrunn
	(Signature)



  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	DAVID ROGERS
	
	/s/ David Rogers
	(Signature)



  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	EPQ LLC, LCOVD PS
		
	By:	 	/s/ Chad Boeding
	Name:	 	Chad Boeding
	Title:	 	CEO



  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	GAURAV GANDHI
	
	/s/ Gaurav Gandhi
	(Signature)



  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	GC&H INVESTMENTS, LLC
		
	By:	 	/s/ Jim Kindler 
	Name:	 	Jim Kindler
	Title:	 	Manager



  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	H. BARTON CO-INVEST FUND IV, LLC
	 By: H. Barton Asset Management, LLC

Its: Managing Member

		
	By:	 	/s/ Harris Barton 
	Name:	 	Harris Barton
	Title:	 	Managing Member



  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	HARRY AND ROSE PAPP REVOCABLE TRUST U/A DTD 2/9/1990
		
	By:	 	/s/ Harry Papp 
	Name:	 	Harry Papp
	Title:	 	Trustee


  

			
	By:	 	/s/ Rose Papp 
	Name:	 	Rose Papp
	Title:	 	Trustee



  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	HARRY SMOUSE
	
	/s/ Harry Smouse
	(Signature)



  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	JASON ODERIO
	
	/s/ Jason Oderio
	(Signature)



  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	JASON VAN TASSEL
	
	/s/ Jason Van Tassel
	(Signature)



  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	JAYA KARNANI
	
	/s/ Jaya Karnani
	(Signature)



  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	JULIE A. WRIGLEY 1999 REVOCABLE TRUST
		
	By:	 	 /s/ Julie A. Wrigley

	Name:	 	 Julie A. Wrigley

	Title:	 	 Trustee




  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	KELLY LEWIS BREZOCZKY AND FLOYD C. LEWIS
	
	 /s/ Kelly Lewis Brezoczky

	(Signature)
	
	 /s/ Floyd C. Lewis

	(Signature)



  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	KENNETH MAHAFFEY
	
	 /s/ Kenneth Mahaffey

	(Signature)



  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	KEVIN KNIGHT
	
	 /s/ Kevin Knight

	(Signature)



  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	KNIGHT FAMILY TRUST (EST 3/10/2003)
		
	By:	 	 /s/ Peggy L. Day

	Name:	 	 Peggy L. Day

	Title:	 	 Trustee

		
	By:	 	 /s/ Delos L. Knight III

	Name:	 	 Delos L. Knight III

	Title:	 	 Trustee




  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	LAKE MIDAS, LLC
		
	By:	 	 /s/ Jason J. Oderio

	Name:	 	 Jason J. Oderio

	Title:	 	 Manager




  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	LATERAL CAPITAL V, L.P.
	By: Lateral Capital V General Partner, LLC
	Its: General Partner
		
	By:	 	 /s/ John Lilly

	Name:	 	 John Lilly

	Title:	 	 Managing Member




  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	PACIFIC PREMIER TRUST CUSTODIAN FBO JOSEPH S. ANDRESEN
		
	By:	 	 /s/ Joseph S. Andresen

	Name:	 	 Joseph S. Andresen

	Title:	 	 Investor




  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	PACIFIC PREMIER TRUST CUSTODIAN FBO ERIK ENGELSON IRA
		
	By:	 	 /s/ Erik T. Engelson

	Name:	 	 Erik T. Engelson

	Title:	 	 Authorized Signatory




  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	PETER AND KRISTA DALTON
	
	/s/ Peter Dalton
	(Signature)
	
	 /s/ Krista Dalton

	(Signature)



  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	PETER S. BROWN
	
	/s/ Peter S. Brown
	(Signature)



  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	PHOENIX VENTURE PARTNERS III LP
		
	By:	 	 /s/ Zachariah Jonasson

	Name:	 	 Zachariah Jonasson

	Title:	 	 Principal




  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	RUSSELL A. BIEHL AND ROBIN R. BIEHL, TRUSTEES OF THE RUSSELL A.
BIEHL AND ROBIN R. BIEHL LIVING TRUST DTD. 6/11/2018
		
	By:	 	 /s/ Russell A. Biehl

	Name:	 	 Russell A. Biehl

	Title:	 	 Trustee

		
	By:	 	 /s/ Robin R. Biehl

	Name:	 	 Robin R. Biehl

	Title:	 	 Trustee




  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	SERAPH INVESTMENTS II, LLC
		
	By:	 	 /s/ Tuff Yen

	Name:	 	 Tuff Yen

	Title:	 	 Manager




  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	STEPHANIE L. GNIBUS
	
	 /s/ Stephanie L. Gnibus

	(Signature)



  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	THE SAADAT FAMILY LIVING TRUST
		
	By:	 	/s/ Mojgan Saadat
	Name:	 	 Mojgan Saadat

	Title:	 	 Co-Trustee




  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	THEODORE L. POST
	
	 /s/ Theodore L. Post

	(Signature)



  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	THERESA BRANDNER
	
	 /s/ Theresa Brandner

	(Signature)



  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	WILLIAM JASON FOX
	
	 /s/ William Jason Fox

	(Signature)



  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	YCVC FUND I, L.P.
	By: YCVC Fund GP, LLC,
	its General Partner
		
	By:	 	 /s/ Kristy Nathoo 

	Name:	 	Kristy Nathoo
	Title:	 	Chief Financial Officer
	
	335 Pioneer Way
	Mountain View, CA 94041
	
	fiancings@ycombinator.com



  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	ECLIPSE VENTURES FUND I, L.P.
	By: Eclipse Ventures GP I, LLC
	Its General Partner
		
	By:	 	 /s/ Justin Butler 

	Name:	 	Justin Butler
	Title:	 	Partner



  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	ECLIPSE FUND III, L.P.
	By: Eclipse GP III, LLC
	Its General Partner
		
	By:	 	 /s/ Justin Butler 

	Name:	 	 Justin Butler

	Title:	 	 Partner




  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	WILMOT VENTURES, L.P. – SERIES A
		
	By:	 	 /s/ Daniel Lurie

	Name:	 	 Daniel Lurie

	Title:	 	 General Partner




  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	DANIEL L. LURIE
	
	 /s/ Daniel L. Lurie

	(Signature)



  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	DANAHER INNOVATION CENTER LLC
		
	By:	 	 /s/ Michael Egholm

	Name:	 	 Michael Egholm

	Title:	 	 Vice President




  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT














 SCHEDULE A 

INVESTORS